The effects of the education program and other factors on the number of sedative medications that older people with dementia regularly consume.

Not Applicable

Completed

• Conditions: Dementia; Mental Health - Studies of normal psychology, cognitive function and behaviour; Neurological - Dementias

• Registration Number: ACTRN12620000268943
• Lead Sponsor: Dementia Training Australia (WA)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-28
• Study Completion: 2021-04-29
• Last Update Posted: 5 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

Diagnosis of dementia in RACFs will be used to select participants for this. Study participants will be identified based on a recorded medical dementia diagnosis, or a diagnosis that will be evaluated during the study. Dementia will be diagnosed using ICD 10 criteria.
-Educational intervention: Staff members (nurses and personal care assistances working in RACF etc.) will be recruited in the study.

Exclusion Criteria

Residents with severe dementia, unable to give verbal answers

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome measure is the prescribing rates of psychotropics (antipsychotics and benzodiazepines) in RACFs.<br>De-identified data of antipsychotics and benzodiazepines in RACFs. We will have reports from pharmacy staff about these medications, dose, frequency, duration etc. [ 3-6 months post the intervention]